279 related articles for article (PubMed ID: 26420046)
1. Initiation of medications for Parkinson's disease: a qualitative description.
Shin JY; Habermann B
J Clin Nurs; 2016 Jan; 25(1-2):127-33. PubMed ID: 26420046
[TBL] [Abstract][Full Text] [Related]
2. Challenges and strategies of medication adherence in Parkinson's disease: A qualitative study.
Shin JY; Habermann B; Pretzer-Aboff I
Geriatr Nurs; 2015; 36(3):192-6. PubMed ID: 25728485
[TBL] [Abstract][Full Text] [Related]
3. Original research: The perioperative experience of patients with Parkinson's disease: a qualitative study.
Anderson LC; Fagerlund K
Am J Nurs; 2013 Feb; 113(2):26-32; quiz 33. PubMed ID: 23334560
[TBL] [Abstract][Full Text] [Related]
4. Adherence to antiparkinsonian medication: an in-depth qualitative study.
Drey N; McKeown E; Kelly D; Gould D
Int J Nurs Stud; 2012 Jul; 49(7):863-71. PubMed ID: 22342100
[TBL] [Abstract][Full Text] [Related]
5. Impact of the Parkinson's disease medication protocol program on nurses' knowledge and management of Parkinson's disease medicines in acute and aged care settings.
Chenoweth L; Sheriff J; McAnally L; Tait F
Nurse Educ Today; 2013 May; 33(5):458-64. PubMed ID: 22626862
[TBL] [Abstract][Full Text] [Related]
6. Perioperative medication withholding in patients with Parkinson's disease: a retrospective electronic health records review.
Fagerlund K; Anderson LC; Gurvich O
Am J Nurs; 2013 Jan; 113(1):26-35; quiz 36. PubMed ID: 23247677
[TBL] [Abstract][Full Text] [Related]
7. Reluctance to start medication for Parkinson's disease: a mutual misunderstanding by patients and physicians.
Mestre TA; Teodoro T; Reginold W; Graf J; Kasten M; Sale J; Zurowski M; Miyasaki J; Ferreira JJ; Marras C
Parkinsonism Relat Disord; 2014 Jun; 20(6):608-12. PubMed ID: 24661467
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of the Parkinson's Disease Medication Beliefs Scale (PD-Rx).
Fleisher JE; Dahodwala NA; Xie SX; Mayo M; Weintraub D; Chodosh J; Shea JA
J Parkinsons Dis; 2016 Apr; 6(2):383-92. PubMed ID: 27061070
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease in the elderly: current management strategies.
Aminoff MJ
Geriatrics; 1987 Jul; 42(7):31-7. PubMed ID: 3110015
[TBL] [Abstract][Full Text] [Related]
10. Medication adherence in Parkinson's.
Wright J; Walker J
Br J Nurs; 2013 Jun 27-Jul 10; 22(12):686-9. PubMed ID: 24151705
[TBL] [Abstract][Full Text] [Related]
11. Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.
Deleu D; Hanssens Y; Northway MG
Drugs Aging; 2004; 21(11):687-709. PubMed ID: 15323576
[TBL] [Abstract][Full Text] [Related]
12. Rotigotine transdermal patch in combination therapy for Parkinson's disease--observations in routine clinical practice.
Ceballos-Baumann A; Häck HJ
Curr Med Res Opin; 2011 Oct; 27(10):1899-905. PubMed ID: 21867400
[TBL] [Abstract][Full Text] [Related]
13. Preferences and concerns for care needs in advanced Parkinson's disease: a qualitative study of couples.
Habermann B; Shin JY
J Clin Nurs; 2017 Jun; 26(11-12):1650-1656. PubMed ID: 27571437
[TBL] [Abstract][Full Text] [Related]
14. Palliative care for Parkinson's disease: Patient and carer's perspectives explored through qualitative interview.
Fox S; Cashell A; Kernohan WG; Lynch M; McGlade C; O'Brien T; O'Sullivan SS; Foley MJ; Timmons S
Palliat Med; 2017 Jul; 31(7):634-641. PubMed ID: 27683476
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Duodopa
Ciurleo R; Corallo F; Bonanno L; Lo Buono V; Di Lorenzo G; Versaci R; Allone C; Palmeri R; Bramanti P; Marino S
J Neurol; 2018 Sep; 265(9):2005-2014. PubMed ID: 29951701
[TBL] [Abstract][Full Text] [Related]
16. Intrajejunal levodopa infusion in advanced Parkinson's disease: long-term effects on motor and non-motor symptoms and impact on patient's and caregiver's quality of life.
Fasano A; Ricciardi L; Lena F; Bentivoglio AR; Modugno N
Eur Rev Med Pharmacol Sci; 2012 Jan; 16(1):79-89. PubMed ID: 22338551
[TBL] [Abstract][Full Text] [Related]
17. Treatment benefit and daily drug costs associated with treating Parkinson's disease in a Parkinson's disease clinic.
Müller T; Voss B; Hellwig K; Josef Stein F; Schulte T; Przuntek H
CNS Drugs; 2004; 18(2):105-11. PubMed ID: 14728057
[TBL] [Abstract][Full Text] [Related]
18. Selegiline: a second look. Six years later: too risky in Parkinson's disease.
Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263
[TBL] [Abstract][Full Text] [Related]
19. Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone.
Reichmann H; Emre M
Expert Rev Neurother; 2012 Feb; 12(2):119-31. PubMed ID: 22288667
[TBL] [Abstract][Full Text] [Related]
20. Safinamide as Add-On Therapy to Levodopa in Mid- to Late-Stage Parkinson's Disease Fluctuating Patients: Post hoc Analyses of Studies 016 and SETTLE.
Cattaneo C; Sardina M; Bonizzoni E
J Parkinsons Dis; 2016; 6(1):165-73. PubMed ID: 26889632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
